Speakers

Director, Medical Affairs, Precision Oncology

Vice President, US Medical Affairs, Precision Oncology

Co-Director, Compass Breast Specialists, Associate Chair, US Oncology Breast Cancer Research Committee
Click on abstract number to see the poster presented at SABCS 2023.
Oncotype DX Data
Update of RSClin® with extended TAILORx follow-up and development and validation of a new tool for risk of late distant recurrence
PO1-02-02 | Sparano
Concordance analysis of paired breast cancer core needle biopsies and surgical excision samples using the Oncotype DX Breast Recurrence Score® assay
PO4-08-09 | Nassar
Magnetic Resonance Imaging and a 12-Gene Expression Assay to Optimize Local Therapy for Ductal Carcinoma In Situ: 5-year clinical outcomes of E4112
GS03-01 | Khan
Impact of age and ovarian function suppression (OFS) on endocrine response to short preoperative endocrine therapy (ET): Results from the multicenter ADAPTcycle trial (n=4,334).
LBO1-05 | Gluz
OncoExTra Data
Comparison of whole exome, whole transcriptome genomic profiling and targeted sequencing with 50-gene panels
PO5-13-05 | Thakkar
Classifying HER2-low breast cancer using a combination of ERBB2 mRNA expression and altered genes
PO5-13-06 | Basu
Prevalence of genomic alterations in Xerna tumor microenvironment subtypes in triple negative breast cancer patients
PO5-13-10 | Basu
PreventionGenetics Data
Cox: Hereditary cancer genetic testing in Puerto Rican females
PO1-08-08 | Cox
Director, Medical Affairs, Precision Oncology
Vice President, US Medical Affairs, Precision Oncology
Co-Director, Compass Breast Specialists, Associate Chair, US Oncology Breast Cancer Research Committee